Cholinesterase inhibitors slow decline in function in Alzheimer's Disease (AD): A 2-year observational study in the Sunnybrook dementia cohort

被引：0
|
作者：
Behl, P
Lanctot, K
Streiner, D
Black, S
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A121 / A121
页数：1
相关论文
共 50 条
  • [1] Cholinesterase inhibitors and Alzheimer's disease: A two-year study in the Sunnybrook dementia cohort
    Behl, Pearl
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    ANNALS OF NEUROLOGY, 2006, 60 : S3 - S3
  • [2] The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort
    Behl, Pearl
    Lanctot, Krista L.
    Streiner, David L.
    Black, Sandra E.
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (06) : 1141 - 1159
  • [3] Cholinesterase inhibitor treatment slows decline in function and multiple cognitive domains in Alzheimer's disease: A 1-year, prospective study in the Sunnybrook Dementia Cohort
    Behl, P
    Black, SE
    Streiner, DL
    Lanctot, K
    NEUROLOGY, 2005, 64 (06) : A145 - A145
  • [4] CHOLINESTERASE INHIBITORS AND KIDNEY FUNCTION DECLINE IN PATIENTS WITH ALZHEIMER'S DEMENTIA
    Xu, Hong
    Garcia-Ptacek, Sara
    Bruchfeld, Annette
    Fu, Edouard
    Shori, Taher Darreh
    Lindholm, Bengt
    Eriksdotter, Maria
    Carrero, Juan Jesus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I847 - I847
  • [5] Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementia
    Xu, Hong
    Garcia-Ptacek, Sara
    Bruchfeld, Annette
    Fu, Edouard L.
    Shori, Taher Darreh
    Lindholm, Bengt
    Eriksdotter, Maria
    Carrero, Juan Jesus
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 166 - 176
  • [6] Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwelling Patients with Alzheimer's Disease A 2-Year Prospective, Multicentre, Cohort Study
    Gardette, Virginie
    Andrieu, Sandrine
    Lapeyre-Mestre, Maryse
    Coley, Nicola
    Cantet, Christelle
    Ousset, Pierre-Jean
    Grand, Alain
    Monstastruc, Jean-Louis
    Vellas, Bruno
    CNS DRUGS, 2010, 24 (05) : 431 - 442
  • [7] Cholinesterase inhibitors selectively benefit attention and executive function in Alzheimer's disease (AD)
    Behl, P.
    Black, S.
    Lanctot, K.
    Streiner, D.
    BRAIN AND COGNITION, 2006, 62 (01) : 85 - 85
  • [8] Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer's Disease and Mixed Dementia
    da Costa Dias, Filipi Leles
    Ferreira Lisboa da Silva, Rose Mary
    de Moraes, Edgar Nunes
    Caramelli, Paulo
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (05) : 476 - 481
  • [9] Pharmacoeconomics of Alzheimer’s disease (AD) treatment with cholinesterase inhibitors
    Jan Versijpt
    Acta Neurologica Belgica, 2012, 112 : 141 - 145
  • [10] Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors
    Versijpt, Jan
    ACTA NEUROLOGICA BELGICA, 2012, 112 (02) : 141 - 145
12345